NCT04350554

Brief Summary

Women living with HIV face multiple challenges regarding pregnancy, encompassing not only their intention to procreate, but also difficulties during the course of pregnancy. Compared to HIV-negative controls, HIV-infected women have a higher risk of pregnancy complications such as preeclampsia, gestational diabetes, or preterm labor. In addition, the treatment of HIV among pregnant women entails specific difficulties, such as changes in bioavailability of antiretroviral drugs, or the concern about the association of certain antiretrovirals with adverse pregnancy outcomes. There is very little evidence about pregnancy among women living with HIV in Spain. Very few studies have been published, performed in single centers or in small cohorts with a limited number of patients. The Cohort of the Spanish AIDS Research Network (CoRIS) offers a unique setting to answer questions that are unlikely to be answered by a single study. The aims of this study are (i) to describe the incidence of pregnancies and their temporal trends from 2004 to 2019, (ii) o describe the clinical and epidemiological characteristics of women who become pregnant, (iii) to assess the diagnostic delay among women diagnosed with HIV infection after becoming pregnant, (iv) to investigate the clinical course during pregnancy and its predictive factors, (v) to describe the antiretroviral treatment administered to pregnant women, (vi) to describe clinical outcomes after pregnancy, (vii) to describe the outcome of the conception in terms of interrupted pregnancies, spontaneous abortions, term pregnancies, type of delivery (vaginal or caesarean section) and HIV infection of the newborn, and (vii) to evaluate attitudes towards pregnancy (ie. planned pregnancy) and social support among women who become pregnant during the year 2020. Study population will be women from the cohort of the Spanish AIDS Research Network (CoRIS) who have become pregnant in the period 2004-2010.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 17, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

July 14, 2020

Status Verified

July 1, 2020

Enrollment Period

Same day

First QC Date

April 9, 2020

Last Update Submit

July 13, 2020

Conditions

Keywords

HIVPregnancyAdverse pregnancy outcomes

Outcome Measures

Primary Outcomes (13)

  • Incidence of pregnancies

    From 2004 to 2019

  • Epidemiological characteristics of women who become pregnant

    Proportion of diagnostic delay among women diagnosed with HIV infection after becoming pregnant

    2004 to 2019

  • Clinical course during pregnancy

    Proportion of women with undetectable viral load at week 36 of pregnancy

    2004 to 2019

  • Opportunistic infections during pregnancy

    Incidence of opportunistic infections throughout pregnancy

    2004 to 2019

  • Persistence of Antiretroviral treatment (ART) during pregnancy

    Time from ART initition to treatment change during pregnancy

    2004 to 2019

  • Antiretroviral treatment (ART) administered to pregnant women

    Distribution of ART regimens administered to women at pregnancy

    2004 to 2019

  • Follow-up after pregnancy

    Rate of lost-to-follow-up during the first year after pregnancy termination

    2004 to 2019

  • Clinical outcomes after pregnancy

    Proportion of women with undetectable viral load 6 months after pregnancy termination

    2004 to 2019

  • Outcome of the conception

    Proportion of interrupted pregnancies, spontaneous abortions and term pregnancies

    2004 to 2019

  • Term pregnancies

    Proportion of term pregnancies

    2004 to 2019

  • Type of delivery

    Proportion of vaginal deliveries

    2004 to 2019

  • HIV infection of the newborn

    Proportion of newborns with HIV infections

    2004 to 2019

  • Attitudes towards pregnancy

    Proportion of unintended pregnancies (unplanned or unwanted at the time of conception)

    Pregnancies during the year 2020

Study Arms (2)

Retrospective pregnancies

Women recruited in CoRIS from January 2004 to November 2019 and who became pregnant during this period.

Other: Pregnancy

Prospective pregnancies

Women recruited in CoRIS from January 2004 to November 2019 who will become pregnant during the year 2020 and who agree to participate in a telephone survey.

Other: Pregnancy

Interventions

To measure and characterize pregnancies and describe the clinical course during pregnancy

Retrospective pregnancies

Eligibility Criteria

Age18 Years+
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The Cohort of the Spanish AIDS Research Network (CoRIS) is a prospective multicentre cohort of HIV-positive treatment-naïve patients aged \>13 years, recruited from 46 centres from 13 Autonomous Regions in the Spanish public healthcare system. Recruitment and follow-up started in 2004 and are still ongoing. From 2004 to the last update in November 2018, 15,509 patients have been included in the cohort. This study will be performed using the update of November 2019, that will be available in June 2020.

You may qualify if:

  • HIV-positive women recruited in CoRIS
  • Became pregnant from January 2004 to November 2019
  • or become pregnant during the year 2020 and agree to participate in a telephone survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HIV Infections

Interventions

Pregnancy

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

ReproductionReproductive Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Central Study Contacts

Inma Jarrin, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientific

Study Record Dates

First Submitted

April 9, 2020

First Posted

April 17, 2020

Study Start

September 1, 2020

Primary Completion

September 1, 2020

Study Completion

June 30, 2021

Last Updated

July 14, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Data cannot be made publicly available because they are owned by a third party, the AIDs Research Network (RIS), and because participants agreed that data would only be used for research projects by RIS or those projects approved by its Executive and Scientific Committee. Interested readers may send requests for the data to proyectoscoris@gmail.com. Requests will be assessed by the Executive and Scientific Committee